Stratos Wealth Partners’s Transphorm, Inc. Common Stock TGAN Stock Holding History

Stratos Wealth Partners’s Portfolio TGAN Stock Details TGAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,203	Closed	-$50.1K	–	1462
2024 Q1	$50.1K	Sell	10,203 -15,437	-60%	-$73.3K	﹤0.01%	1361
2023 Q4	$93.6K	Hold	25,640	–	–	﹤0.01%	1327
2023 Q3	$56.9K	Hold	25,640	–	–	﹤0.01%	1247
2023 Q2	$87.2K	Hold	25,640	–	–	﹤0.01%	1156
2023 Q1	$102K	Buy	25,640 +640	+3%	+$2.82K	﹤0.01%	1083
2022 Q4	$136K	Sell	25,000 -5,000	-17%	-$29.4K	﹤0.01%	1079
2022 Q3	$151K	Sell	30,000 -3,000	-9%	-$14.8K	﹤0.01%	1050
2022 Q2	$126K	Buy	+33,000	New	+$211K	﹤0.01%	1125

Stratos Wealth Partners's TGAN Position: Q2 2024 in Review

Stratos Wealth Partners sold out of Transphorm, Inc. Common Stock (TGAN) in Q2 2024, closing a stake of 10,203 shares — an estimated $50.1K sold.

Stratos Wealth Partners first reported a position in TGAN in Q2 2022 and held it in 8 quarters. The position peaked at $151K in Q3 2022. 0 funds tracked by Wall St. Rank hold TGAN as of Q2 2024.

Stratos Wealth Partners reported no remaining Transphorm, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Stratos Wealth Partners sold 10,203 Transphorm, Inc. Common Stock shares in Q2 2024, an estimated $50.1K.
Stratos Wealth Partners first reported a position in Transphorm, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
Stratos Wealth Partners's Transphorm, Inc. Common Stock position peaked at $151K in Q3 2022.
0 funds tracked by Wall St. Rank held Transphorm, Inc. Common Stock as of Q2 2024.

Based on Stratos Wealth Partners's 13F filing for Q2 2024, filed 24 Jul 2024.